BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-513@pharmaconomics
DTSTAMP:20260707T015522Z
DTSTART;VALUE=DATE:20251201
DTEND;VALUE=DATE:20251202
SUMMARY:PRAX AdCom — ulixacaltamide
DESCRIPTION:An FDA advisory committee reviews ulixacaltamide for essential tremor around Dec 1\, 2025. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1689548/000168954826000028/praxisye2025pr.htm\n\nTrack it: https://pharmaconomics.com/e/513
URL:https://pharmaconomics.com/e/513
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PRAX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR